Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
diabetes diagnosis for Mounjaro) Lab results (HbA1c for diabetes, lipid panel, liver function) Documentation of prior weight-loss attempts or prior diabetes medications tried and failed Letter of medical necessity from your provider PA approval rates for tirzepatide (2025 data): Mounjaro for type 2 diabetes: 78% approved on first submission (Lilly data on file) Zepbound for weight management: 52% approved on first submission (IQVIA prior authorization tracking study 2025) When PA is denied, you have three options: Your provider submits an appeal with additional documentation (approval rate on appeal: 35-40%) You pay cash price without insurance You switch to an alternative (compounded tirzepatide, different medication class) The savings card doesn't expedite PA
Report neck lumps, hoarseness, or trouble swallowing right away
These findings have deepened the understanding of GDM pathophysiology
The new GLP-1 called orforglipron (Foundayo) is also a daily pill, but it can be taken at any time of day, with or without food
US$ 22.37
US$ 20.34
US$ 23.36
US$ 25.95
US$ 21.65
